EPW
ABBV icon

Endeavor Private Wealth’s AbbVie ABBV Stock Holding History

Endeavor Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$615K Buy
2,443
+373
+18% +$80.2K 0.15% 115
2026
Q1 		$450K Buy
2,070
+345
+20% +$76.5K 0.13% 129
2025
Q4 		$394K Buy
1,725
+440
+34% +$100K 0.11% 141
2025
Q3 		$298K Buy
+1,285
New +$262K 0.09% 154

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Endeavor Private Wealth's ABBV Position: Q2 2026 in Review

Endeavor Private Wealth increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $80.2K and bringing the position to 2,443 shares worth $615K. The position accounts for 0.15% of the portfolio, ranked #115.

Endeavor Private Wealth first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Endeavor Private Wealth held 2,443 shares of AbbVie worth $615K as of Q2 2026.
  • Endeavor Private Wealth bought 373 AbbVie shares in Q2 2026, an estimated $80.2K.
  • AbbVie made up 0.15% of Endeavor Private Wealth's portfolio in Q2 2026, its #115 holding.
  • Endeavor Private Wealth first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Endeavor Private Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.